Our Opinion

IN8bio Inc. is on the Cruelty Free Investing use of animals list because they conduct pre-clinical studies of their drugs on animals to assess a product’s safety profile.

Supporting Evidence:

The company stated in the following report that they exploit animals for product testing.

“This program is currently advancing into animal models and provides a unique approach to targeting solid tumor cancers.” (Page 2) Read the full document

Company Description

IN8bio, Inc. is a cell analysis solutions company. The Company is focused on the discovery, development and commercialization of gamma-delta T cell therapies for the treatment of cancer. The Company develops ex vivo-expanded and activated gamma-delta T cell candidates based upon its capabilities in gamma-delta T cell biology, genetic engineering and cell-type-specific manufacturing capabilities, DeltEx platform.

Company Website: https://in8bio.com